Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESET study
ChiCTR-OPN-15007534Phase 4Recruiting
- Sponsor
- Beijing YouAn Hospital
- Start
- Jan 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of peginterferon alfa-2a in Chronic Hepatitis B (CHB) (2 cohorts), sponsored by Beijing YouAn Hospital. Primary endpoint: HBsAg. Started Jan 2016; status: recruiting.
02
Drugs
peginterferon alfa-2a
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-OPN-15007534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-15007534.